DSGN

Design Therapeutics (DSGN)

Design Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DSGN

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/10	20:30	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/10	20:16	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/10	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/10	20:07	GlobeNewswire Inc.	Design Therapeutics Highlights Progress Across Lead GeneTAC® Programs and Reports Fourth Quarter and Full Year 2024 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc
2025/03/03	22:00	GlobeNewswire Inc.	Design Therapeutics to Participate in Leerink’s Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2025/02/08	06:16	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DSGN	Design Therapeutics Inc
2025/02/08	06:15	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:DSGN	Design Therapeutics Inc
2025/01/13	23:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2025/01/07	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2025/01/07	09:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/12/20	08:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/11/13	22:00	GlobeNewswire Inc.	Design Therapeutics to Participate in Multiple Upcoming Investor Conferences	NASDAQ:DSGN	Design Therapeutics Inc
2024/11/08	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/11/08	06:01	GlobeNewswire Inc.	Design Therapeutics Announces Third Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTACTM Portfolio	NASDAQ:DSGN	Design Therapeutics Inc
2024/09/10	21:00	GlobeNewswire Inc.	Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/13	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/10	05:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/05	21:12	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/05	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/08/05	21:00	GlobeNewswire Inc.	Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio	NASDAQ:DSGN	Design Therapeutics Inc
2024/06/18	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/06/18	06:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DSGN	Design Therapeutics Inc
2024/06/18	05:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/09	05:05	GlobeNewswire Inc.	Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones	NASDAQ:DSGN	Design Therapeutics Inc
2024/05/07	19:30	GlobeNewswire Inc.	Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/20	05:01	GlobeNewswire Inc.	Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/19	20:27	IH Market News	US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat	NASDAQ:DSGN	Design Therapeutics Inc
2024/03/12	19:30	GlobeNewswire Inc.	Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update	NASDAQ:DSGN	Design Therapeutics Inc